Omnicell Inc
NASDAQ:OMCL

Watchlist Manager
Omnicell Inc Logo
Omnicell Inc
NASDAQ:OMCL
Watchlist
Price: 44.5 USD -1.07% Market Closed
Market Cap: 2.1B USD
Have any thoughts about
Omnicell Inc?
Write Note

Gross Margin
Omnicell Inc

41.4%
Current
45%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
41.4%
=
Gross Profit
441m
/
Revenue
1.1B

Gross Margin Across Competitors

Country US
Market Cap 2.1B USD
Gross Margin
41%
Country US
Market Cap 36.5B USD
Gross Margin
74%
Country US
Market Cap 31.3B USD
Gross Margin
83%
Country AU
Market Cap 26.4B AUD
Gross Margin
100%
Country US
Market Cap 10.7B USD
Gross Margin
90%
Country US
Market Cap 6.3B USD
Gross Margin
67%
Country JP
Market Cap 934B JPY
Gross Margin
58%
Country US
Market Cap 5.6B USD
Gross Margin
85%
Country SE
Market Cap 53.5B SEK
Gross Margin
47%
Country US
Market Cap 2.4B EUR
Gross Margin
66%
Country CN
Market Cap 16.2B CNY
Gross Margin
43%
No Stocks Found

Omnicell Inc
Glance View

Market Cap
2.1B USD
Industry
Health Care

Omnicell Inc. stands at the intersection of healthcare and technology, sculpting the landscape of medication management systems with its innovative spirit. Founded in 1992, Omnicell has evolved from a small enterprise into a leading provider of automated solutions for medication and supply dispensing, inventory management, and analytics. The company’s core offering, its automated dispensing systems, reshapes how hospitals, pharmacies, and healthcare providers manage medications. By utilizing cutting-edge technology, Omnicell improves efficiency, reduces medication errors, and cuts down on healthcare costs. These systems are embedded in the workflow of healthcare facilities, ensuring that medication management becomes seamless, thus elevating patient safety and clinical outcomes. Revenue streams flow robustly from both product sales and associated services. Omnicell garners income by selling its advanced hardware systems, which include everything from pharmacy carousels to medication robotic systems, and supplements these sales with software solutions that offer predictive analytics and inventory optimization. Beyond the initial sale, a significant part of their business model includes recurring revenue through service contracts, software updates, and customer support. This dual approach not only ensures a steady cash flow but also strengthens customer relationships by consistently providing value over time. As the healthcare industry increasingly leans on technology for streamlined operations and cost management, Omnicell’s strategic positioning allows it to capitalize on the demand for sophisticated medication management solutions.

OMCL Intrinsic Value
52.73 USD
Undervaluation 16%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
41.4%
=
Gross Profit
441m
/
Revenue
1.1B
What is the Gross Margin of Omnicell Inc?

Based on Omnicell Inc's most recent financial statements, the company has Gross Margin of 41.4%.